Finlândia - finlandês - Fimea (Suomen lääkevirasto)

mylan ab - everolimuusi - tabletti - 5 mg - everolimuusi

Finlândia - finlandês - Fimea (Suomen lääkevirasto)

mylan ab - everolimuusi - tabletti - 10 mg - everolimuusi

Finlândia - finlandês - Fimea (Suomen lääkevirasto)

stada arzneimittel ag - sorafenib tosilate - tabletti, kalvopäällysteinen - 200 mg - sorafenibi

União Europeia - finlandês - EMA (European Medicines Agency)

esteve pharmaceuticals gmbh - tiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastiset aineet - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

Finlândia - finlandês - Fimea (Suomen lääkevirasto)

porton biopharma limited - crisantapase - injektio-/infuusiokuiva-aine liuosta varten - 10000 u - asparaginaasi

Finlândia - finlandês - Fimea (Suomen lääkevirasto)

fresenius kabi ab - thiotepa - kuiva-aine välikonsentraatiksi infuusionestettä varten, liuos - 100 mg - tiotepa

Finlândia - finlandês - Fimea (Suomen lääkevirasto)

fresenius kabi ab - thiotepa - kuiva-aine välikonsentraatiksi infuusionestettä varten, liuos - 15 mg - tiotepa

União Europeia - finlandês - EMA (European Medicines Agency)

taiho pharma netherlands b.v. - futibatinib - cholangiocarcinoma - syöpälääkkeet - lytgobi monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.

Finlândia - finlandês - Fimea (Suomen lääkevirasto)

ratiopharm gmbh - tramadoli hydrochloridum - kapseli, kova - 50 mg - tramadoli

União Europeia - finlandês - EMA (European Medicines Agency)

mylan s.a.s. - doketakseli - head and neck neoplasms; carcinoma, non-small-cell lung; adenocarcinoma; prostatic neoplasms; breast neoplasms - antineoplastiset aineet - rintasyövän hoito, keuhkosyöpä (ei-pienisoluinen keuhkosyöpä), eturauhassyöpä, mahasyöpä tai pään ja kaulan syövän erityiset muodot.